Key facts
- This page summarizes Aaron Gorovitz's Form 4 filing for NRX Pharmaceuticals, Inc. (NRXP).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 11 Sep 2023, 09:19.
Aaron Gorovitz - 30 Aug 2023 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)
- Reporting relationship
- Director
- Issuer ticker
- NRXP
- Reported as of
- 30 Aug 2023
- Net transaction value
- +$11,196
- SEC form
- 4
- Accepted by SEC
- 11 Sep 2023, 09:19:33 UTC
- Prior SEC filing
- 22 Nov 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Aaron Gorovitz
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Aaron Gorovitz filed Form 4 for NRX Pharmaceuticals, Inc. (NRXP) on 11 Sep 2023.
Change
- Previous filing in this sequence was filed on 22 Nov 2022.
- Current net transaction value: +$11,196.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NRXP
transaction
Common Stock, par value $0.001 per share
Purchase
- Transaction value
- $11,196
- Shares
- +35,000
- Change %
- +50%
- Price
- $0.3199
- Shares after
- 105,000
- Date
- 30 Aug 2023
- Ownership
- By Spouse
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares of the Common Stock and prices at which the transaction was effected.
Footnote F2
Consists of (i) 8,336 shares of Common Stock held by Samuel David Gorovitz 2017 Irrevocable Trust, (ii) 8,336 shares of Common Stock held by Jeremy Paul Gorovitz 2017 Irrevocable Trust, (iii) 8,336 shares of Common Stock held by Marisa Shey Gorovitz 2017 Irrevocable Trust, (iv) 51,678 shares of Common Stock held by Elizabeth Gorovitz. Aaron Gorovitz is the trustee of the Samuel David Gorovitz 2017 Irrevocable Trust, the Jeremy Paul Gorovitz 2017 Irrevocable Trust, and the Marisa Shey Gorovitz 2017 Irrevocable Trust. Elizabeth Gorovitz is the wife of Aaron Gorovitz;